Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis
Clinical trial NCT03311152 · COMPLETED
Trial details
- NCT number
- NCT03311152
- Sponsor
- Central Hospital, Nancy, France
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2024-10-17
- Enrollment
- 639
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.